Breast Cancer Diagnostics And Therapeutics Market
Global Breast Cancer Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report by Cancer Type (DCIS, IDC, TNBC), Inflammatory Breast Cancer and Others), By Diagnostics (Mammography, Biopsy, PET/CET, Ultrasound, and Others), By Therapeutics(Laboratory testing and Point of care testing) and Forecast 2019-2025 Update Available - Forecast 2024-2030
Global breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.4% during the forecast period. The growth of the market is attributed to the increasing prevalence of breast cancer and rising awareness in emerging countries such as India, China, and Malaysia. Furthermore, the introduction of new technology such as imaging technology and 3D mammography is also estimated to have a significant impact on the growth of the market. The global expenditure on breast cancer therapies and medicines is increasing very rapidly which leads to the high rates of diagnosis and treatment of breast cancer. However, the high cost of breast cancer drugs and surgeries across the developed countries are estimated to be the major constraints in the growth of the market. As per the American Cancer Society, breast cancer treatment can cost more than $100,000 in developed countries such as the US. The lack of awareness in women about breast cancer in developing countries is retraining the market.
Global breast cancer diagnosis and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others.
The companies which are contributing to the growth of the global breast cancer diagnostics and therapeutics market include GlaxoSmithKline PLC, Halozyme, Inc, Hologic Inc., Johnson & Johnson Services Inc., Merck & Co., Inc., Mylan NV, Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
Research Methodology
The market study of global breast cancer diagnostics and therapeutics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report is intended for biotechnology companies, research institutes, hospitals, and government organizations for the overall market and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
- Global breast cancer diagnostics and therapeutics Market Research and Analysis by Cancer Type
- Global breast cancer diagnostics and therapeutics Market Research and Analysis by Diagnostics
- Global breast cancer diagnostics and therapeutics Market Research and Analysis by Therapeutics
The Report Covers
- Comprehensive research methodology of the global breast cancer diagnostics and therapeutics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global breast cancer diagnostics and therapeutics market.
- Insights about market determinants which are stimulating the global breast cancer diagnostics and therapeutics market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. F. Hoffmann-La Roche AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Merck & Co., Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Novartis International AG
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Pfizer Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Siemens Healthcare GmbH
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Breast Cancer Diagnostics and Therapeutics Market by Cancer type
5.1.1. Ductal Carcinoma In-Situ (DCIS)
5.1.2. Invasive Ductal Carcinoma (IDC)
5.1.3. Triple Negative Breast Cancer (TNBC)
5.1.4. Inflammatory Breast Cancer
5.1.5. Others (Invasive lobular carcinoma)
5.2. Global Breast Cancer Diagnostics and Therapeutics Market by Diagnostics
5.2.1. Mammography
5.2.2. Biopsy
5.2.3. PET/CET
5.2.4. Ultrasound
5.2.5. Others (MRI)
5.2.6. Hospitals
5.3. Global Breast Cancer Diagnostics and Therapeutics Market by Therapeutics
5.3.1. Chemotherapy
5.3.2. Hormone Therapy
5.3.3. Targeted Therapy
5.3.4. Others (Radiation Therapy, Surgery)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Agendia NV
7.3. AstraZeneca PLC
7.4. Astellas Pharma Inc.
7.5. Bayer AG
7.6. Bristol-Myers Squibb Co
7.7. Eisai Co., Ltd.
7.8. Eli Lilly and Co.
7.9. GlaxoSmithKline PLC
7.10. Halozyme, Inc
7.11. Hologic Inc.
7.12. Johnson & Johnson Services Inc.
7.13. Merck & Co., Inc.
7.14. Mylan NV
7.15. Novartis International AG
7.16. Pfizer Inc.
7.17. F. Hoffmann-La Roche AG
7.18. Sanofi S.A.
7.19. Siemens Healthcare GmbH
7.20. Takeda Pharmaceutical Co. Ltd.
1. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
2. GLOBAL DCIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL IDC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL TNBC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL INFLAMMATORY BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSTICS, 2018-2025 ($ MILLION)
8. GLOBAL MAMMOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL PET/CET MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL ULTRASOUND MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
14. GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
15. GLOBAL HORMONE THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
16. GLOBAL TARGETED THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
17. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
18. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
19. NORTH AMERICAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
20. NORTH AMERICAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
21. NORTH AMERICAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSTICS, 2018-2025 ($ MILLION)
22. NORTH AMERICAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
23. EUROPEAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
24. EUROPEAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
25. EUROPEAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSTICS, 2018-2025 ($ MILLION)
26. EUROPEAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
27. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
28. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
29. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSTICS, 2018-2025 ($ MILLION)
30. ASIA-PACIFIC BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
31. REST OF THE WORLD BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
32. REST OF THE WORLD BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSTICS, 2018-2025 ($ MILLION)
33. REST OF THE WORLD BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION)
1. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY CANCER TYPE, 2018 VS 2025 (%)
2. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY DIAGNOSTICS, 2018 VS 2025 (%)
3. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY THERAPEUTICS, 2018 VS 2025 (%)
4. GLOBAL BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. US BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
6. CANADA BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
7. UK BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
9. GERMANY BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
10. ITALY BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
11. SPAIN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
12. ROE BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
13. INDIA BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
14. CHINA BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
15. JAPAN BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF ASIA-PACIFIC BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
17. REST OF THE WORLD BREAST CANCER DIAGNOSTICS AND THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
